Agilent Expands Board, Appoints Two New Directors

Agilent ( (A) ) has provided an update.

On May 20, 2025, Agilent Technologies announced the expansion of its Board of Directors from 10 to 12 members, appointing Pascal Soriot and Judy Gawlik Brown as new directors. Soriot, CEO of AstraZeneca, and Brown, founder of Downtown Advisory, bring extensive experience in pharmaceuticals, biotechnology, and strategic leadership, which is expected to support Agilent’s growth initiatives. The company also amended its bylaws to streamline decision-making processes. Additionally, Heidi Kunz retired from the Board after over 20 years of service, marking a significant transition in Agilent’s leadership.

The most recent analyst rating on (A) stock is a Hold with a $130.00 price target. To see the full list of analyst forecasts on Agilent stock, see the A Stock Forecast page.

Spark’s Take on A Stock

According to Spark, TipRanks’ AI Analyst, A is a Outperform.

Agilent scores a 78.6, reflecting strong financial performance and a generally positive outlook from the recent earnings call. While technical indicators suggest short-term positive momentum, the stock appears slightly overvalued based on its P/E ratio. Challenges in certain markets and currency fluctuations pose risks, but the company’s strategic initiatives and growth prospects provide confidence in its ability to navigate these challenges.

To see Spark’s full report on A stock, click here.

More about Agilent

Agilent Technologies Inc. is a global leader in analytical and clinical laboratory technologies, offering a comprehensive range of instruments, software, services, and expertise. The company focuses on delivering insights and innovation to help customers in the scientific community, with a reported revenue of $6.83 billion in fiscal 2023 and approximately 18,000 employees worldwide.

Average Trading Volume: 2,265,509

Technical Sentiment Signal: Sell

Current Market Cap: $32.34B

Find detailed analytics on A stock on TipRanks’ Stock Analysis page.